View in EDS HTML Full Text PDF Full Text

Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia.

Saved in:
Bibliographic Details
Title: Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia.
Authors: Ma, Ya-Fang1,2,3 (AUTHOR), Lu, Ying4 (AUTHOR), Wu, Qian5 (AUTHOR), Lou, Yin-Jun1,2,3 (AUTHOR), Yang, Min1,2,3 (AUTHOR), Xu, Jie-Yu1,2,6 (AUTHOR), Sun, Cai-Hong1 (AUTHOR), Mao, Li-Ping1,2,3 (AUTHOR), Xu, Gai-Xiang1,2,3 (AUTHOR), Li, Li1,2,3 (AUTHOR), Huang, Jian1,2,3,7 (AUTHOR), Wang, Huai-Yu8 (AUTHOR), Lou, Li-Jiang9 (AUTHOR), Meng, Hai-Tao1,2,3 (AUTHOR), Qian, Jie-Jing1,2,3 (AUTHOR), Yu, Wen-Juan1,2,3 (AUTHOR), Wei, Ju-Ying1,2,3 (AUTHOR), Li, Zhen-Yu10 (AUTHOR), Zhu, Xue-Lu11 (AUTHOR), Yan, Xiao-Yan11 (AUTHOR)
Source: Journal of Hematology & Oncology. 10/18/2022, Vol. 15 Issue 1, p1-4. 4p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17568722
DOI:10.1186/s13045-022-01368-3